|
|
| | GNE-490 Basic information |
| Product Name: | GNE-490 | | Synonyms: | GNE-490;2-(2-Amino-4-methyl-5-pyrimidinyl)-alpha,alpha-dimethyl-4-(4-morpholinyl)thieno[3,2-d]pyrimidine-6-methanol;GNE490;GNE 490;CS-2657;Thieno[3,2-d]pyrimidine-6-methanol, 2-(2-amino-4-methyl-5-pyrimidinyl)-α,α-dimethyl-4-(4-morpholinyl)-;2-(2-(2-amino-4-methylpyrimidin-5-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)propan-2-ol;PI3Kβ,GNE 490,PI3Kδ,Mammalian target of Rapamycin,mTOR,GNE-490,MCF7.1,PI3K,PI3Kα,Phosphoinositide 3-kinase,PI3Kγ,breast cancer,Inhibitor,GNE490,inhibit | | CAS: | 1033739-92-2 | | MF: | C18H22N6O2S | | MW: | 386.47 | | EINECS: | | | Product Categories: | | | Mol File: | 1033739-92-2.mol |  |
| | GNE-490 Chemical Properties |
| storage temp. | 4°C, protect from light | | solubility | DMSO : ≥ 100 mg/mL (258.75 mM) |
| | GNE-490 Usage And Synthesis |
| Description | GNE-490 is a highly selective pan-PI3K inhibitor, demonstrating selectivity over mTOR. |
| | GNE-490 Preparation Products And Raw materials |
|